All sponsors

Stemline Therapeutics, Inc.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS7
PHASE 3 / 2-31
RECRUITING2
READOUTS ≤12 MONTHS3
READOUT SLIPPED >6 MO60%

Delay Index: of 5 active trials registered more than a year ago, 3 have moved their primary completion (readout) date by more than 6 months since first registration (median +12.0 months). See all sponsors →

Open Stemline Therapeutics, Inc. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
ELCIN
NCT05596409
P2Active, not recruitingMetastatic Breast Cancer612026-11 (+27 mo)
ELECTRA
NCT05386108
P1/2RecruitingBreast Neoplasms; Brain Neoplasms732026-12 (+12 mo)
ELEVATE
NCT05563220
P1/2Active, not recruitingBreast Cancer; Metastatic Breast Cancer4352026-12-27 (+24 mo)
TRILLIUM
NCT06456463
P2Active, not recruitingAcute Myeloid Leukemia852028-02-09
MEN2312
NCT07873827
P1/2Not yet recruitingHematological Malignancy1152028-05-12
Elacestrant
NCT07766018
P2RecruitingBreast Cancer702028-10
ELEGANT
NCT06492616
P3Active, not recruitingBreast Cancer45562029-08